Solna
Sweden
4
2015-01-29
3
2016-06-28
These are the the leading inventors for applications assigned to CLANOTECH AB:
CLANOTECH AB based in Solna, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Quinoline compounds which are anti-angiogenic integrin alpha5 beta1 inhibitors for use in the treatment of fibrosis or fibrosis-related diseases
#2 | 2014-01-16 ✅ Patent 8,957,092 granted on 2015-02-17Quinoline derivatives and their use as tyrosine kinase inhibitors
#3 | 2012-03-15SUBSTITUTED QUINOLINES FOR USE AS VEGF INHIBITORS
#4 | 2011-03-03 ✅ Patent 8,557,843 granted on 2013-10-15Quinoline derivatives and their use as tyrosine kinase inhibitors
Also check out Clanotech AB's (Solna, Sweden) applicant profile with 1 patent applications submitted.
178456 ⎘